BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 22243793)

  • 21. Effect of CCL5 on dimethylarginine dimethylaminohydrolase-1 production in vascular smooth muscle cells from spontaneously hypertensive rats.
    Kim HY; Kim JH; Kim HS
    Cytokine; 2013 Oct; 64(1):227-33. PubMed ID: 23834755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease in the synthesis and release of calcitonin gene-related peptide in dorsal root ganglia of spontaneously hypertensive rat: role of nitric oxide synthase inhibitors.
    Chen QQ; Li D; Guo R; Luo D; Yang J; Hu CP; Li YJ
    Eur J Pharmacol; 2008 Oct; 596(1-3):132-7. PubMed ID: 18782573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma level of asymmetric dimethylarginine in hypertensive rats facilitates platelet aggregation: role of plasma tissue factor.
    Li D; Guo R; Chen QQ; Hu CP; Chen X
    Can J Physiol Pharmacol; 2011 Mar; 89(3):151-8. PubMed ID: 21423288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
    Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
    World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of asymmetric dimethylarginine involved in the cardioprotective effect of losartan in spontaneously hypertensive rats.
    Li D; Xia K; Li NS; Luo D; Wang S; Jiang DJ; Deng HW; Li YJ
    Can J Physiol Pharmacol; 2007 Aug; 85(8):783-9. PubMed ID: 17901888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
    Ronden RA; Houben AJ; Teerlink T; Bakker JA; Bierau J; Stehouwer CD; De Leeuw PW; Kroon AA
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F149-56. PubMed ID: 22552932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotoxemia exacerbates kidney injury and increases asymmetric dimethylarginine in young bile duct-ligated rats.
    Huang LT; Hung JF; Chen CC; Hsieh CS; Yu HR; Hsu CN; Tain YL
    Shock; 2012 Apr; 37(4):441-8. PubMed ID: 22193869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury.
    Lee Y; Mehrotra P; Basile D; Ullah M; Singh A; Skill N; Younes ST; Sasser J; Shekhar A; Singh J
    J Pharmacol Exp Ther; 2021 Feb; 376(2):181-189. PubMed ID: 33214214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.
    Chen GF; Wagner L; Sasser JM; Zharikov S; Moningka NC; Baylis C
    Nephrol Dial Transplant; 2010 Nov; 25(11):3518-25. PubMed ID: 20484304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension.
    Li D; Chen BM; Peng J; Zhang YS; Li XH; Yuan Q; Hu CP; Deng HW; Li YJ
    J Hypertens; 2009 Jun; 27(6):1224-32. PubMed ID: 19462497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R; Ueda S; Yamagishi S; Kaida Y; Matsumoto Y; Fukami K; Hayashida A; Matsuoka H; Kato S; Kimoto M; Okuda S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1162-9. PubMed ID: 19015171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A; Zhao Y; Warren JS
    Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
    Brooks ER; Langman CB; Wang S; Price HE; Hodges AL; Darling L; Yang AZ; Smith FA
    Pediatr Nephrol; 2009 Jan; 24(1):129-34. PubMed ID: 18830716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
    Pullamsetti S; Kiss L; Ghofrani HA; Voswinckel R; Haredza P; Klepetko W; Aigner C; Fink L; Muyal JP; Weissmann N; Grimminger F; Seeger W; Schermuly RT
    FASEB J; 2005 Jul; 19(9):1175-7. PubMed ID: 15827267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of acute renal injury on arginine and methylarginines metabolism.
    Sukhovershin RA; Gilinsky MA
    Ren Fail; 2013; 35(10):1404-11. PubMed ID: 23991715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
    Kanzelmeyer N; Tsikas D; Chobanyan-Jürgens K; Beckmann B; Vaske B; Illsinger S; Das AM; Lücke T
    Amino Acids; 2012 May; 42(5):1765-72. PubMed ID: 21472412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
    Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.
    Milewski K; Bogacińska-Karaś M; Fręśko I; Hilgier W; Jaźwiec R; Albrecht J; Zielińska M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?
    Quintana-Villamandos B; Delgado-Baeza E
    Med Hypotheses; 2016 Feb; 87():44-7. PubMed ID: 26826640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.